The Short Version

The Trump administration lost court case after court case trying to cancel research grants through executive orders alone. So the Office of Management and Budget did the logical next step: turn those orders into formal federal rules.

On May 29, 2026, OMB published a 400-plus-page proposed regulation that would rewrite the foundational rules governing ALL federal grants across ALL agencies.

What the Rule Actually Does

According to Inside Higher Ed, the proposed rules would require federal agency heads to "designate one or more senior appointees" to review "all discretionary awards" before they go out the door. Political appointees, not scientists, get final say.

Peer review — the gold standard that built American scientific dominance — gets demoted. It becomes a secondary consideration, not the primary filter, according to Ars Technica's analysis of the document.

The rule also explicitly allows any agency to cancel any existing grant at any time if a political appointee decides it isn't consistent with "applicable law, federal agency priorities, and the national interest." No hard definition of "national interest" is provided. That vagueness is deliberate.

OMB confirmed the intent directly to Inside Higher Ed: "grantees out of alignment may now be suspended or terminated."

Why the Administration Is Doing This Now

This isn't new policy — it's old policy with legal armor.

Last August, Trump signed an executive order directing agencies to put senior appointees in charge of grant decisions. Courts repeatedly struck down grant cancellations that followed, ruling the administration lacked proper legal authority.

Formal rulemaking changes that calculus. Once a rule clears the public comment period — 45 days in this case — and gets published in the Federal Register, it carries regulatory weight that executive orders alone do NOT.

The administration is essentially converting its wish list into durable law. Smart legal strategy. Terrible news for researchers.

The Culture War Provisions

This is where the document gets messy — and where honest coverage requires calling it like it is.

The rule flat-out bans federal funding for several categories of research. According to Ars Technica's review of the document, these include:

• Research involving "theories of disparate-impact liability"
• Work the administration classifies as DEI
• Research touching "gender ideology," which the document defines as anything that "deny[ies] the biological reality of sex or the sex binary in humans"

On the biological sex definition: banning scientific study of chromosomal disorders because they involve X and Y chromosome variations conflates defending biological facts with preventing research into biological variation. These are different categories of action.

The document also introduces what Ars Technica accurately describes as a political litmus test: agencies may consider an applicant's "affiliations with organizations engaged in activities that violate Federal law, undermine public safety or national security, or advocate for" — and the source text cuts off there. The comparison to McCarthy-era loyalty tests is apt.

The document also cites a Heritage Foundation editorial as a source for claims about PEPFAR — a foreign aid program for HIV prevention in Africa. Citing a think tank op-ed as evidence in a federal rulemaking document falls short of what government agencies should be held to.

The Internal Contradiction Nobody Is Talking About

The document contradicts itself in a way that could become a serious legal vulnerability.

According to Ars Technica's analysis, the rule states that "Federal financial assistance must NOT discriminate on the basis of the viewpoint" — and then, in the same document, bans funding for specific viewpoints it dislikes.

You cannot simultaneously demand viewpoint neutrality and enforce viewpoint discrimination. Pick one. The administration didn't.

What Legitimate Concerns Exist

Some of what OMB is complaining about is real, even if the proposed solution is wrong.

Federal grant spending HAS at times funded projects with dubious scientific merit and obvious ideological slant. Government waste is real. Accountability in how taxpayer dollars fund research is a completely legitimate demand.

Jules Barbati-Dajches of the Union of Concerned Scientists told Inside Higher Ed that political review "would replace merit with loyalty." That's a fair warning. Pure peer review has also been gamed — insular academic communities that fund each other's preferred projects aren't above criticism.

The right answer is accountability WITH scientific integrity, not political override of scientific merit.

What This Means for Regular People

If you get cancer, the research that might save your life was almost certainly funded by an NIH grant. If you take a medication that works, the same applies. American pharmaceutical and medical supremacy is built on a federal grant system that prioritized scientific quality above politics.

This rule puts a political appointee — someone who owes their job to whoever is in the White House — between researchers and funding. That appointee can kill a grant. Any grant. Any time. No rigorous justification required.

The 45-day public comment window is open. After that, this becomes the law of the land unless courts intervene again.

American science built the modern world. This rule is a bet that political loyalty produces better research than scientific merit.

History says otherwise.